Vienna Biocenter

What Vienna Biocenter does

Vienna BioCenter is a life sciences research campus located in Vienna, Austria, comprising seven research institutions: the Institute of Molecular Pathology (IMP), Institute of Molecular Biotechnology (IMBA), Gregor Mendel Institute of Molecular Plant Biology (GMI), Max Perutz Labs, the Center for Microbiology and Environmental Systems Science (CeMESS), the University of Vienna Faculty of Life Sciences, and AITHYRA (the newest institution, which began operations at Marxbox in 2026). The campus hosts approximately 2,800 total staff — including 2,000 scientists, 400+ PhD students, and 147 active research groups drawn from 80 nationalities — conducting fundamental and biomedical research across molecular biology, genetics, cell biology, neuroscience, plant sciences, computational biology, and biochemistry. Vienna BioCenter is credited with major discoveries including the foundational CRISPR/Cas9 work underlying Emmanuelle Charpentier's 2020 Nobel Prize in Chemistry, human brain organoids, chromosome segregation mechanisms, epigenetics research, and the 1001 Genomes project, producing 350 publications per year — the highest publication rate of any life sciences institute in Austria according to the Nature Index.

Name

Vienna Biocenter

Legal name

Vienna BioCenter

Website

https://viennabiocenter.org

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vienna BioCenter is a Vienna-based life sciences research campus comprising seven research institutions, 2,800 staff, and 42 biotech companies. It conducts fundamental research across molecular biology, genetics, and neuroscience, operates ten shared core facilities, and produces 350 publications annually.

Ownership category

akta.pro rank

Product category

Life Sciences Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Colleges, Universities, and Professional Schools (6113)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Life sciences research
• Molecular biology research
• Biomedical research campus
• Core research facilities
• Biotech incubation

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Grants: Funding from European Research Council (ERC), Austrian Science Fund (FWF), and other national/international grant agencies supporting fundamental research
2. Biotech Company Ecosystem: 42 biotech companies on campus generate economic activity through research collaborations, licensing, and potential spinoffs
3. Educational Programs: PhD programs, summer school, internships, and postdoctoral training attracting talent globally

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Vienna BioCenter is an integrated life sciences research campus in Vienna, Austria, operating seven constituent research institutions and ten shared scientific core facilities (VBCF) that deliver specialized services such as electron microscopy, next generation sequencing, proteomics, metabolomics, and advanced microscopy. The campus provides shared infrastructure, collaborative research environment, and educational programs (PhD, summer school, internships, postdoctoral training) to 2,000 scientists from 80 nationalities, while hosting 42 biotech companies for industry-academic translation.

Product overview

Vienna BioCenter is a leading life sciences research campus in Europe that functions as an integrated ecosystem combining research, companies, and education on a single campus. The organization is not a single unified product but rather a collaborative research infrastructure comprising seven major research institutions (GMI, IMBA, IMP, Max Perutz Labs, CeMESS, Faculty of Life Sciences, and AITHYRA), the Vienna BioCenter Core Facilities (VBCF) providing shared scientific services, 42 biotech companies, and comprehensive education/training programs. The research institutions conduct basic biomedical and plant research across all areas of life sciences, while VBCF offers specialized scientific services including computational biology training, electron microscopy, histology, advanced microscopy (BioOptics), metabolomics, next generation sequencing, plant sciences, preclinical phenotyping, protein technologies, proteomics, and the Vienna Drosophila Resource Center. The ecosystem hosts over 2,000 scientists and produces approximately 350 publications annually.

Differentiator

Problem solved

Functional benefit

Products and services

• Vienna BioCenter Core Facilities (VBCF) A collection of ten shared scientific service facilities providing specialized instrumentation and expertise to researchers, including electron microscopy, histology, advanced microscopy (BioOptics), metabolomics, next generation sequencing, plant sciences, preclinical phenotyping, protein technologies, proteomics, computational biology training, and the Vienna Drosophila Resource Center.
• Education and Training Programs
• Research Campus Infrastructure A collaborative life sciences research ecosystem comprising seven research institutions (GMI, IMBA, IMP, Max Perutz Labs, CeMESS, Faculty of Life Sciences, AITHYRA) offering state-of-the-art laboratories and shared resources for over 2,000 scientists from 80 countries.
• Vienna Drosophila Resource Center

Quantifiable outcome

• 350 publications per year - highest in Austria for life sciences
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• University of Vienna (Faculty of Life Sciences)coreStrategic or Co-development PartnerOne of seven research institutions at Vienna BioCenter, conducting life sciences education and research within the campus ecosystem.
• IMP (Institute of Molecular Pathology)coreStrategic or Co-development PartnerLeading research institution at Vienna BioCenter focused on molecular pathology research, part of the campus ecosystem since its founding.
• IMBA (Institute of Molecular Biotechnology)coreStrategic or Co-development PartnerResearch institution at Vienna BioCenter conducting molecular biotechnology research, co-located on campus.
• GMI (Gregor Mendel Institute of Molecular Plant Biology)coreStrategic or Co-development PartnerResearch institution focused on plant molecular biology, part of Vienna BioCenter campus ecosystem.
• Max Perutz LabscoreStrategic or Co-development PartnerResearch institution at Vienna BioCenter named after Nobel laureate Max Perutz, conducting molecular biology research.
• CeMESS (Center for Microbiology and Environmental Systems Science)coreStrategic or Co-development PartnerUniversity of Vienna center at Vienna BioCenter focused on microbiology and environmental systems science.
• AITHYRAcoreStrategic or Co-development PartnerResearch institution at Vienna BioCenter, recently started operations at Marxbox facility on campus.
• Pfizer (via Valneva collaboration)coreStrategic or Co-development PartnerCollaboration on Lyme Disease Vaccine VLA15 development through campus company Valneva's partnership.
• Boehringer Ingelheim (via a:head partnership)minorStrategic or Co-development PartnerGrass Roots Innovation Prize awarded to a:head bio AG, a campus company, demonstrating pharmaceutical industry recognition.

Scale indicators10 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• MaRS Discovery District: Large urban innovation district in Toronto co-locating university research, hospital partners, and startup companies across multiple sectors including health. Comparable as a multi-institution research-and-incubation campus, though broader in scope than VBC's life-sciences focus.

Direct peers

• Singapore Biopolis: Purpose-built biomedical research and commercialization hub in Singapore hosting A*STAR research institutes and private biotech tenants. Comparable as a government-anchored life-sciences campus ecosystem with shared facilities, talent concentration, and industry incubation.
• Cambridge Biomedical Campus: Cluster of research institutions, hospitals, and biotech companies co-located on a single site in Cambridge, UK. Directly comparable to Vienna BioCenter as an integrated life-sciences campus combining academic research, pharma presence, and company incubation in one footprint.
• Babraham Research Campus: Life-sciences campus in Cambridge, UK combining BBSRC-funded research institutes with on-site biotech companies and accelerator programs. Directly comparable as a multi-institution campus with shared core facilities and a company incubation track record.
• EMBL Heidelberg: European Molecular Biology Laboratory's main site offering intergovernmental basic research in molecular life sciences with shared core facilities. Comparable as a non-commercial European basic-research institute producing top-tier publications and hosting visiting researchers.
• Leiden Bio Science Park: Largest life-sciences cluster in the Netherlands co-locating Leiden University medical center, research institutes, and 200+ biomedical companies. Comparable as a European integrated research park model with academic-industry tenant mix.
• Mission Bay (UCSF): UCSF's life-sciences campus in San Francisco combining university research institutes, hospital functions, and biotech tenants in a single district. Comparable as a high-density academic-industry life-sciences ecosystem attracting global talent.

Regional players

• BioPark Regensburg: German biotechnology campus at the University of Regensburg combining academic research institutes with biotech company tenants and shared facilities. Comparable as a mid-sized European life-sciences cluster with academic-industry co-location.
• Karolinska Science Park / Hagastaden: Life-sciences campus in Stockholm anchored by Karolinska Institutet, hosting research groups, core facilities, and biotech companies. Comparable as a Nordic academic-medical life-sciences cluster with shared infrastructure and industry tenants.
• Science Park Amsterdam: Amsterdam-based science park anchored by University of Amsterdam and VU University research groups, hosting life-sciences startups and scale-ups. Comparable as a European research park with academic-industry integration in a single urban campus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/viennabiocenter
• LinkedInlinkedin.com/company/vienna-biocenter

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vienna Biocenter